SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-004046
Filing Date
2021-04-07
Accepted
2021-04-07 16:01:51
Documents
13
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210520xdef14a.htm DEF 14A 1733570
2 GRAPHIC tmb-20210520xdef14a001.jpg GRAPHIC 12378
3 GRAPHIC tmb-20210520xdef14a009.jpg GRAPHIC 3324
4 GRAPHIC tmb-20210520xdef14a008.jpg GRAPHIC 69802
5 GRAPHIC tmb-20210520xdef14a033.jpg GRAPHIC 124671
6 GRAPHIC tmb-20210520xdef14a011.jpg GRAPHIC 3836
7 GRAPHIC tmb-20210520xdef14a032.jpg GRAPHIC 145205
8 GRAPHIC tmb-20210520xdef14a014.jpg GRAPHIC 3451
9 GRAPHIC tmb-20210520xdef14a026.jpg GRAPHIC 13596
10 GRAPHIC tmb-20210520xdef14a010.jpg GRAPHIC 3977
11 GRAPHIC tmb-20210520xdef14a025.jpg GRAPHIC 14566
12 GRAPHIC tmb-20210520xdef14a012.jpg GRAPHIC 3741
13 GRAPHIC tmb-20210520xdef14a013.jpg GRAPHIC 3009
  Complete submission text file 0001558370-21-004046.txt   2289501
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37372 | Film No.: 21812077
SIC: 2834 Pharmaceutical Preparations